On ECHEMI
Home > Drugs > ORxes Biopharmaceuticals (Shenyang) Co., Ltd.
ORxes Biopharmaceuticals (Shenyang) Co., Ltd.
  • Founded in:

    2004-08-09
  • Country:

    China China
  • Address:

    No. 176, Shenbei Road, Huishan Economic Development Zone, Shenbei New District, Shenyang
  • Tax NO.:

    91210100764362386F
  • Registered Funds:

    115 million yuan
  • Email:

Related Drugs
Metoclopramide Tablets
The main ingredient of this product is metoclopramide, and its chemical name is N-[(2-diethylamino)ethyl]-4-amino-2-methoxy-5-chloro-benzamide.
Name Description Content CAS NO. Registered Holders
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide

This product is a dopamine 2 (D2) receptor antagonist, and also has a 5-hydroxytryptamine 4 (5-HT4) receptor agonist effect, and has a mild inhibitory effect on 5-HT3 receptors. It can act on dopamine receptors in the medullary emetic chemoreceptor zone (CTZ) to increase the threshold of CTZ, and has a strong central antiemetic effect. This product can also block hypothalamic dopamine receptors, inhibit prolactin inhibitory factor, and promote the secretion of prolactin, so it has a certain lactation effect. The inhibitory effect on other parts of the central nervous system is relatively small, with a weak sedative effect and less hypnotic effect. The effect on the gastrointestinal tract is mainly in the upper digestive tract, promoting the movement of the stomach and upper intestinal segments; increasing the tension of the gastrointestinal sphincter in the resting state, increasing the tension and contraction amplitude of the lower esophageal sphincter, and increasing the pressure at the lower end of the esophagus.

More

This product is a dopamine 2 (D2) receptor antagonist, and also has a 5-hydroxytryptamine 4 (5-HT4) receptor agonist effect, and has a mild inhibitory effect on 5-HT3 receptors. It can act on dopamine receptors in the medullary emetic chemoreceptor zone (CTZ) to increase the threshold of CTZ, and has a strong central antiemetic effect. This product can also block hypothalamic dopamine receptors, inhibit prolactin inhibitory factor, and promote the secretion of prolactin, so it has a certain lactation effect. The inhibitory effect on other parts of the central nervous system is relatively small, with a weak sedative effect and less hypnotic effect. The effect on the gastrointestinal tract is mainly in the upper digestive tract, promoting the movement of the stomach and upper intestinal segments; increasing the tension of the gastrointestinal sphincter in the resting state, increasing the tension and contraction amplitude of the lower esophageal sphincter, and increasing the pressure at the lower end of the esophagus.

364-62-5 17
Glutamate tablets
The main ingredient of this product is glutamic acid, and its chemical name is: L-2-aminoglutaric acid.
Name Description Content CAS NO. Registered Holders
L-Glutamic acid

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

More

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

56-86-0 17
Glutamate tablets
The main ingredient of this product is glutamic acid, and its chemical name is: L-2-aminoglutaric acid.
Name Description Content CAS NO. Registered Holders
L-Glutamic acid

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

More

In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.

56-86-0 17
Acyclovir Tablets
The main ingredient of this product is acyclovir, and its chemical name is: 9-[(2-hydroxyethoxy)methyl]guanine
Name Description Content CAS NO. Registered Holders
Acyclovir

This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

More

This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

59277-89-3 50
Sucralfate chewable tablets
The main ingredient of this product is sucralfate.
Name Description Content CAS NO. Registered Holders
Sucralfate

It can form a thin film on the surface of damaged gastric mucosa, thereby resisting the invasion of gastric acid on the mucosa and protecting the gastric mucosa. In addition, sucralfate can absorb pepsin and neutralize gastric acid, but the effect is weak.

More

It can form a thin film on the surface of damaged gastric mucosa, thereby resisting the invasion of gastric acid on the mucosa and protecting the gastric mucosa. In addition, sucralfate can absorb pepsin and neutralize gastric acid, but the effect is weak.

54182-58-0 22
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.